Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

NCT04670003 | Completed

• 1 other identifier: WP-2020-05
• Study Type: observational
• Target: 4,975
• Locations: 1 country
• Sites: 1

Brief Summary

A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases. Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.

Conditions

Covid19

Outcome Measures

Primary Outcomes (1)

• Description of the methods of contamination of patients

  Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)

  2 months

Secondary Outcomes (2)

• Evaluation in time of the spread of the virus during the 2nd epidemic wave.

  2 months

• Evaluation in space of the spread of the virus during the 2nd epidemic wave.

  2 months

Study Arms (1)

users

users of web-application

Other: users

Interventions

users OTHER

Data of users of the web-application

users

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All users of the application contaminated with COVID 19 who have not objected to the use of their data

You may qualify if:

• users of the application
• not having objected to the use of their data

You may not qualify if:

• \- user who does not have a complete questionnaire

Sponsors & Collaborators

• Weprom: lead
• Kelindi: collaborator

Study Sites (1)

Institut Interrégional de Cancérologie

Le Mans, 72000, France

Location

Related Publications (1)

• Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study. J Med Internet Res. 2021 May 4;23(5):e26932. doi: 10.2196/26932.

  PMID: 33878018 DERIVED

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Fabrice DENIS, MD

  Institut Interrégional de Cancerologie et Kelindi

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 14, 2020
• First Posted: December 17, 2020
• Study Start: January 2, 2021
• Primary Completion: March 30, 2021
• Study Completion: March 30, 2021
• Last Updated: April 8, 2021

Record last verified: 2020-12

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)